semaglutide prediabetes weight loss trial progression to diabetes Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 Semaglutide 2.4 mg weekly vs

Researchers are exploring GLP-1 receptor agonists, drugs first developed to treat Type 2 diabetes, as potential therapies

Promising microbiota-modulating strategies, including the use of probiotics, prebiotics, and fecal microbiota transplantation (FMT), have shown beneficial effects [23, 24]

Understanding IV Glutathione Why Detoxification Matters The world we're living in today is a toxic minefield from vaccines to pesticides to antibiotic-laden foods to mercury-poisoned fish to pollution both indoors and outdoors

Melanoacanthoma: Deep black plaque not preferentially occurring in sunlight-exposed areas

Whilst promising, human studies are still needed

Similarly, you have to keep taking GLP-1s to treat obesity